According to G1 Therapeutics 's latest financial reports the company's current earnings are $58.19 Million USD. In 2023 the company made an earning of -$34.82 Million USD, an increase over its 2022 earnings that were of -$0.14 Billion USD. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -$34.02 Million | -2.28% |
2023 | -$34.82 Million | -74.29% |
2022 | -$0.14 Billion | -5.14% |
2021 | -$0.15 Billion | 48.61% |
2020 | -$96.07 Million | -23.45% |
2019 | -$0.13 Billion | 40.54% |
2018 | -$89.29 Million | 46.45% |
2017 | -$60.97 Million | 100.61% |
2016 | -$30.4 Million |